TipRanks
Go Ultimate55% OFF

Alzamend Neuro (9ZT) Income Statement

Alzamend Neuro Income Statement

Last quarter (Q1 2027), Alzamend Neuro's total revenue was $0.00. In Q1, Alzamend Neuro's net income was $-3.03M. See Alzamend Neuro’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementApr 26Apr 25Apr 24Apr 23Apr 22
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 8.77M$ 4.50M$ 9.94M$ 14.87M$ 12.32M
Depreciation and Amortization$ 110.74K$ 50.74K$ 50.74K$ 23.07K$ 3.55K
$ -8.66M$ -4.45M$ -9.89M$ -14.85M$ -12.31M
$ -8.77M$ -4.50M$ -9.94M$ -14.87M$ -12.32M
$ -5.54K$ -18.03K$ -10.10K$ -7.70K$ -42.52K
$ -8.77M$ -4.51M$ -9.95M$ -14.88M$ -12.36M
$ -8.77M$ -4.51M$ -9.95M$ -14.88M$ -12.36M
Per Share Metrics
Basic EPS$ -2.63$ -11.32$ -132.33$ -205.97$ -187.31
Diluted EPS$ -2.63$ -11.32$ -132.33$ -205.97$ -187.31
Weighted Average Shares Outstanding3.34M398.00K75.00K72.00K65.00K
Weighted Average Shares Outstanding (Diluted)3.34M450.80K75.17K72.24K66.00K

Currency in USD

Alzamend Neuro Earnings and Revenue History

-18M-12M-6M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin